Corcept Therapeutics Incorporated logo

Corcept Therapeutics Incorporated

NASDAQ:CORT

Overview | Financials
Company Name Corcept Therapeutics Incorporated
Symbol CORT
Currency USD
Price 51.66
Market Cap 5,412,676,500
Dividend Yield 0%
52-week-range 20.84 - 62.22
Industry Biotechnology
Sector Healthcare
CEO Dr. Joseph K. Belanoff M.D.
Website https://www.corcept.com

An error occurred while fetching data.

About Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have

Related Stocks

AbCellera Biologics Inc. logo

AbCellera Biologics Inc.

ABCL

2.77 USD

Arvinas, Inc. logo

Arvinas, Inc.

ARVN

17.22 USD

Fate Therapeutics, Inc. logo

Fate Therapeutics, Inc.

FATE

1.255 USD

Canopy Growth Corporation logo

Canopy Growth Corporation

CGC

2.22 USD

Amicus Therapeutics, Inc. logo

Amicus Therapeutics, Inc.

FOLD

9.21 USD

Tilray Brands, Inc. logo

Tilray Brands, Inc.

TLRY

1.18 USD

PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc.

PTCT

41.81 USD

Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM

23.3 USD

Allscripts Healthcare Solutions, Inc. logo

Allscripts Healthcare Solutions, Inc.

MDRX

9.25 USD

Alignment Healthcare, Inc. logo

Alignment Healthcare, Inc.

ALHC

13.51 USD

Financials

Numbers are in millions USD

Numbers are in millions USD